PAHO assists the Member States at the national and subregional level in the formulation, implementation, and evaluation of pharmaceutical policies as part of their health policies in order to guarantee equitable access to quality essential medicines and promote their rational, evidence-based use by health professionals and the community.

Through a participatory process with all actors from the pharmaceutical sector led by the Ministry of Health based on a situation diagnosis, discussion was promoted and a consensus was reached that lead to approval of pharmaceutical policy through an administrative act such as a ministerial resolution, presidential decree, or law (e.g., Brazil, Colombia, Ecuador, Paraguay, the Dominican Republic and, more recently, Panama, where the policy has not yet been approved). In the case of the subregional policies, the policies of the Andean Community, MERCOSUR, and Central America are noteworthy.

Key Information

Pharmaceutical Situation Reports

Transparencia en el sector farmacéutico

National and Subnational Pharmaceutical Policies

- National

Generic Medicines Strategy

Pharmaceutical Country Profiles